Institutional Review Board, Hospital for Special Surgery
November 09, 2009
The safety of study participants is our top priority. The trial is approved and periodically reviewed by an Institutional Review Board (IRB), which includes doctors, administrators, ethicists, and members of the general public. The safety of clinical trials is reviewed by the U.S. Food and Drug Administration.
Before enrolling in a clinical trial, the investigator will explain the purpose of the trial, its expected benefits, any possible risks or side effects, and what your role will be. This is the time to ask questions! If you want to join the trial, you must sign the informed consent documents. You can leave a clinical trial at any time without penalty.
For further information, see Understanding Clinical Trials.
Lorene Janowski, Occupational Therapist
This study proposes to review three cases of patients who presented with upper extremity issues, post hemispherectomy, to determine similarities between the patients and the outcomes of subsequent upper extremity surgical procedures. The patients have already been determined via retrospective chart review.
1. Surgically underwent hemispherectomy
2. Present with upper extremity issues
3. Surgically treated by the principle investigator for upper extremity issue
1. Not treated by PI for upper extremity issue post-hemispherectomy.